During the past decade, Nagano Municipal Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nagano Municipal Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Japan Clinical Cancer Research Organization" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagano Municipal Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Korean Gynecologic Oncology Group" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Nagano Municipal Hospital" are "Colorectal Cancer" (2 trials), "Gastric Cancer" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Nagano Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Nagano Municipal Hospital" are "Drug" (9 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagano Municipal Hospital" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nagano Municipal Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nagano Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nagano Municipal Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".